AAAAAA

   
Results: 1-11 |
Results: 11
The integration of anthracyclines in the treatment of advanced ovarian cancer
Authors: Luck, HJ Du Bois, A Weber, B Pfisterer, J Goupil, A Kuhn, W Barats, JC Blohmer, J Mousseau, M Schroder, W Meier, W Mobus, V Richter, B
Citation: Hj. Luck et al., The integration of anthracyclines in the treatment of advanced ovarian cancer, INT J GYN C, 11, 2001, pp. 34-38
Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer - a dose-finding study by the Arbeitsgemeinschaft Gynakologische Onkologie (AGO) Ovarian Cancer Study Group
Authors: du Bois, A Luck, HJ Pfisterer, J Schroeder, W Blohmer, JU Kimmig, R Moebus, V Quaas, J
Citation: A. Du Bois et al., Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer - a dose-finding study by the Arbeitsgemeinschaft Gynakologische Onkologie (AGO) Ovarian Cancer Study Group, ANN ONCOL, 12(8), 2001, pp. 1115-1120
Clinical picture: Nail changes secondary to docetaxel
Authors: Wasner, G Hilpert, F Baron, R Pfisterer, J
Citation: G. Wasner et al., Clinical picture: Nail changes secondary to docetaxel, LANCET, 357(9260), 2001, pp. 910-910
Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation
Authors: Kiechle, M Jacobsen, A Schwarz-Boeger, U Hedderich, J Pfisterer, J Arnold, N
Citation: M. Kiechle et al., Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation, CANCER, 91(3), 2001, pp. 534-540
Refinement of primary chemotherapy for advanced ovarian cancer
Authors: Pfisterer, J
Citation: J. Pfisterer, Refinement of primary chemotherapy for advanced ovarian cancer, ONKOLOGIE, 23, 2000, pp. 31-34
Second-line chemotherapie after platinum or platinum and paclitaxel-based chemotherapy for ovarian cancer: A systematic review
Authors: du Bois, A Luck, HJ Bauknecht, T Pfisterer, J Meier, W
Citation: A. Du Bois et al., Second-line chemotherapie after platinum or platinum and paclitaxel-based chemotherapy for ovarian cancer: A systematic review, GEBURTSH FR, 60(1), 2000, pp. 41-58
Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization
Authors: Kiechle, M Hinrichs, M Jacobsen, A Luttges, J Pfisterer, J Kommoss, F Arnold, N
Citation: M. Kiechle et al., Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization, AM J PATH, 156(6), 2000, pp. 1827-1833
A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers
Authors: Arnold, N Gross, E Schwarz-Boeger, U Pfisterer, J Jonat, W Kiechle, M
Citation: N. Arnold et al., A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers, HUM MUTAT, 14(4), 1999, pp. 333-339
First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: A phase I/II study of the Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer Study Group
Authors: du Bois, A Luck, HJ Bauknecht, T Meier, W Richter, B Kuhn, W Quaas, J Pfisterer, J
Citation: A. Du Bois et al., First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: A phase I/II study of the Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer Study Group, J CL ONCOL, 17(1), 1999, pp. 46-51
Ductal carcinoma in situ of the breast
Authors: Pfisterer, J
Citation: J. Pfisterer, Ductal carcinoma in situ of the breast, ONKOLOGIE, 22, 1999, pp. 22-24
A fast, highly sensitive and cheap tool for mutation analysis of complex genes
Authors: Arnold, N Gross, E Schwarz-Boeger, U Pfisterer, J Jonat, W Kiechle, M
Citation: N. Arnold et al., A fast, highly sensitive and cheap tool for mutation analysis of complex genes, DIS MARKER, 15(1-3), 1999, pp. 118-118
Risultati: 1-11 |